![]() | |
Names | |
---|---|
IUPAC name
[(2R)-2-hydroxy-3-[hydroxy-[(2R,3R,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]-oxyphosphoryl]oxypropyl] hexadecanoate | |
Identifiers | |
3D model (JSmol) |
|
PubChem CID |
|
| |
Properties | |
C25H49O12P | |
Molar mass | 572.629 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Lysophosphatidylinositol (LPI, lysoPI), or L-α-lysophosphatidylinositol, is an endogenous lysophospholipid and endocannabinoid neurotransmitter.[1] LPI, along with its 2-arachidonoyl- derivative, 2-arachidonoyl lysophosphatidylinositol (2-ALPI), have been proposed as the endogenous ligandsofGPR55.[2][3][4][5]
| |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amino acid-derived |
| ||||||||||||||||||||||
Lipid-derived |
| ||||||||||||||||||||||
Nucleobase-derived |
| ||||||||||||||||||||||
Vitamin-derived |
| ||||||||||||||||||||||
Miscellaneous |
|
![]() | This biochemistry article is a stub. You can help Wikipedia by expanding it. |